Premium
Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR‐5 extract with warfarin and theophylline in rats
Author(s) -
Panossian Alexander,
Hovhannisyan Areg,
Abrahamyan Hasmik,
Gabrielyan Emil,
Wikman Georg
Publication year - 2009
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.2631
Subject(s) - theophylline , pharmacokinetics , pharmacology , warfarin , pharmacodynamics , medicine , drug interaction , rhodiola rosea , anticoagulant , salidroside , atrial fibrillation
Abstract Significant pharmacokinetic/pharmacodynamic interactions between various herbal products and drugs being substrates of cytochrome P450 have recently been reported. The aim of this study was to determine whether Rhodiola rosea SHR‐5 extract interacts with warfarin and theophylline when administered concomitantly. Thus, concomitant treatment of rats with theophylline and SHR‐5 did not give rise to significant effects on the pharmacokinetics of theophylline. Simultaneous administration of SHR‐5 and warfarin did not alter significantly the pharmacokinetics or the anticoagulant activity of warfarin. It is concluded that SHR‐5 might be of value in the treatment of patients with mild or moderate depression, and that its interaction with co‐administered drugs is likely to be negligible. Copyright © 2008 John Wiley & Sons, Ltd.